2-chloroadenosine has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, SL; Liu, YX; Wang, MJ; Zhang, JC; Zheng, DX | 1 |
| Clausen, NT; Hansen, PB; Larsen, CR | 1 |
| Azuma, I; Ishizaki, Y; Kato, I; Kimizuka, F; Makabe, T; Matsumoto, Y; Murata, J; Okuyama, H; Saiki, I; Yoneda, J | 1 |
3 other study(ies) available for 2-chloroadenosine and Cancer of Liver
| Article | Year |
|---|---|
[Mechanisms of sensitization by 8-chloro-adenosine of human tumor cells to TRAIL-induced apoptosis].
Topics: 2-Chloroadenosine; Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Membrane Glycoproteins; NF-kappa B; TNF-Related Apoptosis-Inducing Ligand; Transfection; Tumor Necrosis Factor-alpha | 2005 |
Aggressive growth of epithelial carcinomas following treatment with nucleoside analogues.
Topics: 2-Chloroadenosine; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Immunosuppressive Agents; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Liver Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nucleosides; Vidarabine | 2002 |
Recombinant fusion polypeptide with cell- and heparin-binding domains of fibronectin inhibits liver metastasis of L5178Y-ML25 lymphoma cells.
Topics: 2-Chloroadenosine; Animals; Binding Sites; Cell Adhesion; Fibronectins; G(M1) Ganglioside; Glycosphingolipids; Heparin; Leukemia L5178; Liver Neoplasms; Mice; Neoplasm Metastasis; Recombinant Fusion Proteins; Structure-Activity Relationship; Survival Analysis | 1991 |